Position history for DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in CRINETICS PHARMACEUTICALS IN
DRIEHAUS CAPITAL MANAGEMENT LLC holds 6.4M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $232.3M as of 2026-Q1. The position was increased (+0.1% shares). CRNX represents 1.7% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$232.3M
Current Shares
6.4M
Total Value Change
-$41.5M
Total Shares Change
+283,749
Other major holders of CRNX: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 6.4M |
+0.1% |
| $232.3M |
| 1.7% |
| $40.12 |
48 |
| 2025-Q4 | Decreased | 6.4M | -1.4% | $297.3M | 2.0% | $47.39 | 0 |
| 2025-Q3 | Increased | 6.5M | +1.3% | $270M | 1.9% | $43.51 | 49 |
| 2025-Q2 | Increased | 6.4M | +2.6% | $184.1M | 1.5% | $29.96 | 49 |
| 2025-Q1 | Increased | 6.2M | +1.6% | $209.3M | 2.0% | $34.73 | 53 |
| 2024-Q4 | Increased | 6.1M | +4.3% | $314M | 2.6% | $50.67 | 55 |
| 2024-Q3 | Decreased | 5.9M | -3.7% | $300.7M | 2.6% | $50.75 | 0 |
| 2024-Q2 | Increased | 6.1M | +16.9% | $273.8M | 2.6% | $44.79 | 61 |